[HTML][HTML] Diagnostic utility of galectin-3 in thyroid cancer

CG Chiu, SS Strugnell, OL Griffith, SJM Jones… - The American journal of …, 2010 - Elsevier
Galectin-3 (Gal-3), which has received significant recent attention for its utility as a
diagnostic marker for thyroid cancer, represents the most well-studied molecular candidate …

Application of immunohistochemistry in thyroid pathology

H Liu, F Lin - Archives of Pathology and Laboratory …, 2015 - meridian.allenpress.com
Context Accurate classification of follicular-patterned thyroid lesions is not always an easy
task on routine surgical hematoxylin-eosin–stained or cytologic fine-needle aspiration …

Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis

LL de Matos, AB Del Giglio, CO Matsubayashi… - Diagnostic …, 2012 - Springer
Background To distinguish between malignant and benign lesions of the thyroid gland
histological demonstration is often required since the fine-needle aspiration biopsy method …

Immunohistochemistry in the pathologic diagnosis and management of thyroid neoplasms

A Crescenzi, Z Baloch - Frontiers in endocrinology, 2023 - frontiersin.org
The use of immunohistochemistry cannot be underestimated in the everyday practice of
thyroid pathology. It has evolved over the years beyond the traditional confirmation of thyroid …

Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules

HA Saleh, B Jin, J Barnwell, O Alzohaili - Diagnostic pathology, 2010 - Springer
Background Thyroid nodules are common among adults though only a small percentage is
malignant, which can histologically mimic benign nodules. Accurate diagnosis of these …

Do benign thyroid nodules have malignant potential? An evidence-based review

N Arora, T Scognamiglio, B Zhu, TJ Fahey Iii - World journal of surgery, 2008 - Springer
Background Benign thyroid tumors account for most nodular thyroid disease. Determination
of whether a thyroid nodule is benign or malignant is a major clinical dilemma and underlies …

Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature

D Dunđerović, JM Lipkovski, I Boričic, I Soldatović… - Diagnostic …, 2015 - Springer
Background Nodular follicular lesions of thyroid gland comprise benign and malignant
neoplasms, as well as some forms of hyperplasia.“Follicular” refers to origin of cells and in …

[HTML][HTML] Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors

A Menz, R Bauer, M Kluth, CM von Bargen… - Human Pathology, 2021 - Elsevier
Summary To evaluate cytokeratin 19 (CK19) expression in normal and cancerous tissues,
15,977 samples from 122 tumor types and 608 samples of 76 normal tissue types were …

[HTML][HTML] Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer

V Arcolia, F Journe, F Renaud… - Oncology …, 2017 - spandidos-publications.com
Currently, fine‑needle aspiration is the most frequently used pre‑operative technique for
diagnosis of malignant thyroid tumors, however, pathologists are unable to reach efficient …

Discovery and identification of potential biomarkers of papillary thyroid carcinoma

Y Fan, L Shi, Q Liu, R Dong, Q Zhang, S Yang, Y Fan… - Molecular Cancer, 2009 - Springer
Background Thyroid carcinoma is the most common endocrine malignancy and a common
cancer among the malignancies of head and neck. Noninvasive and convenient biomarkers …